129 related articles for article (PubMed ID: 38198163)
1. Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status.
Olofsson Bagge R; Mikiver R; Marchetti MA; Lo SN; van Akkooi ACJ; Coit DG; Ingvar C; Isaksson K; Scolyer RA; Thompson JF; Varey AHR; Wong SL; Lyth J; Bartlett EK
JAMA Surg; 2024 Mar; 159(3):260-268. PubMed ID: 38198163
[TBL] [Abstract][Full Text] [Related]
2. Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy?
Hosein S; Drebin HM; Kurtansky NR; Olofsson Bagge R; Coit DG; Bartlett EK; Marchetti MA
J Surg Oncol; 2023 Jun; 127(7):1167-1173. PubMed ID: 36905337
[TBL] [Abstract][Full Text] [Related]
3. Clinical Utility of Melanoma Sentinel Lymph Node Biopsy Nomograms.
Drebin HM; Hosein S; Kurtansky NR; Nadelmann E; Moy AP; Ariyan CE; Bello DM; Brady MS; Coit DG; Marchetti MA; Bartlett EK
J Am Coll Surg; 2024 Jan; 238(1):23-31. PubMed ID: 37870230
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Melanoma Institute of Australia's Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma.
Maddineni S; Dizon MP; Muralidharan V; Young LA; Sunwoo JB; Baik FM; Swetter SM
Ann Surg Oncol; 2024 Apr; 31(4):2737-2746. PubMed ID: 38216800
[TBL] [Abstract][Full Text] [Related]
6. Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram.
Lo SN; Ma J; Scolyer RA; Haydu LE; Stretch JR; Saw RPM; Nieweg OE; Shannon KF; Spillane AJ; Ch'ng S; Mann GJ; Gershenwald JE; Thompson JF; Varey AHR
J Clin Oncol; 2020 Aug; 38(24):2719-2727. PubMed ID: 32530761
[TBL] [Abstract][Full Text] [Related]
7. Utility of a Model for Predicting the Risk of Sentinel Lymph Node Metastasis in Patients With Cutaneous Melanoma.
Marchetti MA; Dusza SW; Bartlett EK
JAMA Dermatol; 2022 Jun; 158(6):680-683. PubMed ID: 35475908
[TBL] [Abstract][Full Text] [Related]
8. The Integrated i31-GEP Test Outperforms the MSKCC Nomogram at Predicting SLN Status in Melanoma Patients.
Tassavor M; Martin BJ; Glazer AM
Anticancer Res; 2023 Oct; 43(10):4511-4516. PubMed ID: 37772588
[TBL] [Abstract][Full Text] [Related]
9. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Memorial Sloan Kettering Cancer Center nomogram for predicting non-sentinel lymph node metastasis in sentinel lymph node-positive breast-cancer patients.
Bi X; Wang Y; Li M; Chen P; Zhou Z; Liu Y; Zhao T; Zhang Z; Wang C; Sun X; Qiu P
Onco Targets Ther; 2015; 8():487-93. PubMed ID: 25750542
[TBL] [Abstract][Full Text] [Related]
11. Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram.
Chue KM; Yong WS; Thike AA; Ahmed SS; Li HH; Wong CY; Ho GH; Madhukumar P; Tan BK; Ong KW; Tan PH
J Clin Pathol; 2014 Feb; 67(2):112-9. PubMed ID: 24048026
[TBL] [Abstract][Full Text] [Related]
12. Improving Selection for Sentinel Lymph Node Biopsy Among Patients With Melanoma.
Miller JR; Lo SN; Nosrati M; Stretch JR; Spillane AJ; Saw RPM; Shannon KF; Nieweg OE; Ch'ng S; Kim KB; Leong SP; Thompson JF; Scolyer RA; Kashani-Sabet M
JAMA Netw Open; 2023 Apr; 6(4):e236356. PubMed ID: 37074717
[TBL] [Abstract][Full Text] [Related]
13. Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population.
Woods JF; De Marchi JA; Lowery AJ; Hill AD
Ir J Med Sci; 2015 Dec; 184(4):769-73. PubMed ID: 24997756
[TBL] [Abstract][Full Text] [Related]
14. Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas.
Winder AA; Boyer Z; Ch'ng S; Stretch JR; Saw RPM; Shannon KF; Pennington TE; Nieweg OE; Varey AHR; Scolyer RA; Thompson JF; Cust AE; Lo SN; Spillane AJ; Smith AL
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38802717
[TBL] [Abstract][Full Text] [Related]
15. A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
Friedman C; Lyon M; Torphy RJ; Thieu D; Hosokawa P; Gonzalez R; Lewis KD; Medina TM; Rioth MJ; Robinson WA; Kounalakis N; McCarter MD; Gleisner AL
J Surg Oncol; 2019 Dec; 120(7):1276-1283. PubMed ID: 31602665
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms.
D'Eredità G; Troilo VL; Giardina C; Napoli A; Rubini G; Fischetti F; Berardi T
Clin Breast Cancer; 2010 Dec; 10(6):445-51. PubMed ID: 21147687
[TBL] [Abstract][Full Text] [Related]
17. Assessment of an existing and modified model for predicting non sentinel lymph node metastasis in breast cancer patients with positive sentinel node biopsy.
Al-Masri M; Darwazeh G; El-Ghanem M; Hamdan B; Sughayer M
Gulf J Oncolog; 2013 Jan; 1(13):15-22. PubMed ID: 23339977
[TBL] [Abstract][Full Text] [Related]
18. [Risk factors of non-sentinel lymph node metastasis and performance of MSKCC nomogramin breast cancer patients with metastatic sentinel lymph node].
Huang J; Chen X; Fei X; Huang O; Wu J; Zong Y; Zhu L; He J; Chen W; Li Y; Shen K
Zhonghua Wai Ke Za Zhi; 2015 Dec; 53(12):941-6. PubMed ID: 26850667
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Probability of Non-sentinel Lymph Node Metastasis in Breast Cancer Patients with Sentinel Lymph Node Metastasis using Two Different Methods.
Başoğlu İ; Çelik MF; Dural AC; Ünsal MG; Akarsu C; Baytekin HF; Kapan S; Alış H
J Breast Health; 2015 Oct; 11(4):172-179. PubMed ID: 28331717
[TBL] [Abstract][Full Text] [Related]
20. Predicting sentinel node positivity in patients with melanoma: external validation of a risk-prediction calculator (the Melanoma Institute Australia nomogram) using a large European population-based patient cohort.
El Sharouni MA; Varey AHR; Witkamp AJ; Ahmed T; Sigurdsson V; van Diest PJ; Scolyer RA; Thompson JF; Lo SN; van Gils CH
Br J Dermatol; 2021 Aug; 185(2):412-418. PubMed ID: 33657653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]